SumanaDevataMD

PubMed

• 3 citations
  Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study.
  Christopher Staffi Buradagunta, Zhuping Garacci, Anita D'Souza, Binod Dhakal, Sumana Devata, Siegfried Janz, Aaron P Thrift, Parameswaran Hari, Melinda Stolley, Jing Dong> ;Blood Cancer Journal. 2022 May 25
• 2 citations
  Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.
  Marcus Geer, Charles E. Foucar, Sumana Devata, Lydia L. Benitez, Anthony J. Perissinotti, Bernard L. Marini, Dale L. Bixby> ;Journal of the National Comprehensive Cancer Network. 2021 Aug 17
• 5 citations
  Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
  Christopher D'Angelo, Walter Hanel, Yi Chen, Menggang Yu, David T. Yang, Ling Guo, Reem Karmali, Madelyn Burkart, Colleen Ciccosanti, Kevin A. David, Zachary Risch, Ca...> ;Hematological Oncology. 2021 Aug 4
• 14 citations
  Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation
  Nan Hu, Fangyang Wang, Tianyu Sun, Zhengfan Xu, Jing Zhang, Denzil Bernard, Shilin Xu, Shaomeng Wang, Mark S. Kaminski, Sumana Devata, Tycel Phillips, Sami N. Malek> ;Clinical Cancer Research. 2021 Apr 15
• 79 citations
  A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
  Nancy L. Bartlett, Alex F. Herrera, Eva Domingo-Domenech, Amitkumar Mehta, Andres Forero-Torres, Ramón García-Sanz, Philippe Armand, Sumana Devata, Antonia Rodriguez I...> ;Blood. 2020 Nov 19
• 3 citations
  Clinical application of next generation sequencing in lymphoma
  Anthony J Scott, Molly Tokaz, Maryann Shango, Sumana Devata, Shannon A. Carty, Mark S. Kaminski, Arul M. Chinnaiyan, Tycel Phillips, Ryan A. Wilcox> ;Leukemia & Lymphoma. 2021 Mar 21
• 42 citations
  Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
  Auris Huen, Bradley M. Haverkos, Jasmine Zain, Ramchandren Radhakrishnan, Mary Jo Lechowicz, Sumana Devata, Neil J. Korman, Lauren C. Pinter-Brown, Yasuhiro Oki, Praja...> ;Cancers. 2020 Aug 15
• 3 citations
  Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas
  Taylor M Weis, Bernard L. Marini, Victoria R Nachar, Anna Brown, Tycel Phillips, Julia Brown, Ryan A. Wilcox, Mark S. Kaminski, Sumana Devata, Anthony J. Perissinotti> ;Leukemia & Lymphoma. 2020 Apr 15
• 1 citations
  Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
  Justin H Reid, Bernard L. Marini, Victoria R Nachar, Anna Brown, Sumana Devata, Anthony J. Perissinotti> ;Critical Reviews in Oncology/hematology. 2020 Apr 1
• 13 citations
  Use of GMI-1271, an E-selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis.
  Sumana Devata, Dana E. Angelini, Susan Blackburn, Angela E. Hawley, Daniel D. Myers, Jordan K. Schaefer, Martina V Hemmer, John L. Magnani, Helen M. Thackray, Thomas W...> ;Research and Practice in Thrombosis and Haemostasis. 2020 Feb 1
• 4 citations
  Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.
  Jennifer Girard, John C. Reneau, Sumana Devata, Ryan A. Wilcox, Mark S. Kaminski, Jessica Mercer, Shannon A. Carty, Tycel Phillips> ;Oncotargets and Therapy. 2019 Sep 30
• 174 citations
  Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
  Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro, Sumana Devata, Scott D. Gitlin, Mark S. Kaminski, Alice M. Cusick, Tycel Phill...> ;The Lancet. Haematology. 2019 Sep 16
• 15 citations
  Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.
  Marcus Geer, Emily Roberts, Maryann Shango, Brian G. Till, Stephen D. Smith, Hashim Abbas, Brian T. Hill, Jason B. Kaplan, Paul M. Barr, Paolo Caimi, Deborah M. Stephe...> ;British Journal of Haematology. 2019 Jul 1
• 1 citations
  PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma.
  Justin H Reid, Bernard L. Marini, Victoria R Nachar, Sumana Devata, Anthony J. Perissinotti> ;The Lancet. Oncology. 2019 Apr 1
• 18 citations
  Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL).
  Janie Y. Zhang, Robert Briski, Sumana Devata, Mark S. Kaminski, Tycel Phillips, Tera Mayer, Nathanael G. Bailey, Ryan A. Wilcox> ;American Journal of Hematology. 2018 Mar 1
• 13 citations
  Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
  Carlos Murga-Zamalloa, Avery Polk, Walter Hanel, Pinki Chowdhury, Noah A. Brown, Alexandra C. Hristov, Nathanael G. Bailey, Tianjiao Wang, Tycel Phillips, Sumana Devat...> ;Oncotarget. 2017 Dec 6
• 17 citations
  A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
  Philip S. Boonstra, Avery Polk, Noah A. Brown, Alexandra C. Hristov, Nathanael G. Bailey, Mark S. Kaminski, Tycel Phillips, Sumana Devata, Tera Mayer, Ryan A. Wilcox> ;American Journal of Hematology. 2017 Dec 1
• 5 citations
  Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.
  Petros Grivas, Sumana Devata, Rami Khoriaty, Philip S. Boonstra, Joshua Michael Ruch, Kevin McDonnell, Leonel Hernandez-Aya, Joshua Murray Wilfong, Jeffrey B. Smerage,...> ;Journal of Cancer Education. 2017 Dec 1
• 16 citations
  Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders
  Tycel Phillips, Sumana Devata, Ryan A. Wilcox> ;Journal for Immunotherapy of Cancer. 2016 Dec 20
• 20 citations
  Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents
  Sumana Devata, Ryan A. Wilcox> ;American Journal of Clinical Dermatology. 2016 Feb 29
• 30 citations
  Desmoid Tumors: A Comprehensive Review of the Evolving Biology, Unpredictable Behavior, and Myriad of Management Options
  Sumana Devata, Rashmi Chugh> ;Hematology/oncology Clinics of North America. 2013 Oct 1
• 14 citations
  Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor
  Sumana Devata, Edward J. Kim> ;Case Reports in Oncology. 2012 Sep 1
• Myeloma (MM) after autologous transplant (AutoHCT): Biochemical versus clinical progression.
  Cornell RF, Singh V, Devata S, Saad AA, Palmer JM, Hari P> ;J. Clin. Oncol.. 2011-05-20
• 21 citations
  Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sections
  Sumana Devata, Parameswaran Hari, Natalia Markelova, Rongshan Li, Richard A. Komorowski, Vinod B. Shidham> ;Cytojournal. 2011 Jan 1
• 21 citations
  Performing and processing FNA of anterior fat pad for amyloid
  Vinod B. Shidham, Bryan Hunt, Safwan Jaradeh, Alexandru Barboi, Sumana Devata, Parameswaran Hari> ;Journal of Visualized Experiments. 2010 Oct 30
• Join now to see all

Abstracts/Posters

• Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
  Sumana Devata, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymph... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Cen... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018